A MUTATION (G281E) OF THE HUMAN UROPORPHYRINOGEN DECARBOXYLASE GENE CAUSES BOTH HEPATOERYTHROPOIETIC PORPHYRIA AND OVERT FAMILIAL PORPHYRIA-CUTANEA-TARDA - BIOCHEMICAL AND GENETIC-STUDIES ON SPANISH PATIENTS
Ag. Roberts et al., A MUTATION (G281E) OF THE HUMAN UROPORPHYRINOGEN DECARBOXYLASE GENE CAUSES BOTH HEPATOERYTHROPOIETIC PORPHYRIA AND OVERT FAMILIAL PORPHYRIA-CUTANEA-TARDA - BIOCHEMICAL AND GENETIC-STUDIES ON SPANISH PATIENTS, Journal of investigative dermatology, 104(4), 1995, pp. 500-502
Hepatoerythropoietic porphyria is a severe cutaneous porphyria caused
by deficiency of uroporphyrinogen decarboxylase and is considered to b
e the homozygous form of familial (type II) porphyria cutanea tarda. T
o elucidate further the relation between these conditions, we studied
five Spanish families with hepatoerythropoietic porphyria and nine unr
elated Spanish patients with familial porphyria cutanea tarda. Immunor
eactive and catalytic uroporphyrinogen decarboxylase was decreased by
greater than 95% in the five patients with hepatoerythropoietic porphy
ria. Hepatic uroporphyrinogen decarboxylase activity was decreased to
22% of normal. Four patients were homozygous for a mutation (G281E) or
iginally identified in a Tunisian family; the fifth patient was a comp
ound heterozygote for this mutation. The calculated carrier frequency
for G281E in Spain is one in 1800. None of the nine familial porphyria
cutanea tarda patients carried the G281E mutation. However, one G281E
heterozygote in a family with hepatoerythropoietic porphyria had over
t porphyria cutanea tarda. These findings suggest that the G281E mutat
ion is functionally less severe than erythrocyte measurements indicate
, that its clinical penetrance is very low in heterozygotes, and that,
for this particular mutation, hepatoerythropoietic porphyria is the h
omozygous form of familial porphyria cutanea tarda.